主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ESLA
#3526
Estrella Immunopharma, Inc. Common Stock
1.2
2
+0.83%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.83%
每月变动
+10.91%
6个月变化
+29.79%
年变化
+25.77%
前一天收盘价
1.2
1
Open
1.2
2
Bid
Ask
Low
1.2
2
High
1.2
2
交易量
1
市场
股票
医疗保健
ESLA
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
TTM
Key stats
Total common shares outstanding
5.85 M
2.33 M
35.2 M
—
Valuation ratios
Enterprise value
—
—
36.11 M
149.91 M
Price to earnings ratio
—
—
-4.07
-0.42
Price to sales ratio
—
—
7.93
—
Price to cash flow ratio
—
—
-1.86
-25.78
Price to book ratio
—
—
7.9
-12.16
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
-0.01
-0.1
-1.64
-4.99
Return on equity %
0.25
0.44
-1.71
-1.98
Return on invested capital %
-2.2
-24.51
-557.25
361.44
Gross margin %
—
—
100
—
Operating margin %
—
—
-194.49
—
EBITDA margin %
—
—
—
—
Net margin %
—
—
-194.53
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
8.42
0.05
24.65
1.28
Inventory turnover
—
—
—
—
Asset turnover
—
—
0.53
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
Per share metrics
Operating cash flow per share
-0.27
-0.24
-0.59
-0.11
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
0.41
0.01
0.15
0.14
Net current asset value per share
0.52
0.01
0.16
0.18
Tangible book value per share
-0.85
-0.22
0.14
-0.48
Working capital per share
0.46
-0.23
0.16
-0.63
Book value per share
-0.85
-0.52
0.14
-0.48
新闻
Estrella在淋巴瘤试验中报告100%完全缓解率
Estrella reports 100% complete response rate in lymphoma trial
Estrella将在ASTCT会议上展示CD19靶向细胞疗法的一期数据
Estrella to present phase 1 data on CD19-targeted cell therapy
Estrella Immunopharma收到纳斯达克关于延迟年度股东大会的通知
Estrella Immunopharma receives Nasdaq notice for delayed annual meeting
Estrella Immunopharma完成800万美元注册直接发行
Estrella Immunopharma closes $8 million registered direct offering
Estrella Immunopharma股价在宣布800万美元融资后下跌
Estrella Immunopharma stock falls after announcing $8 million offering
Estrella Immunopharma通过注册发行筹集800万美元资金
Estrella Immunopharma raises $8 million through registered offering